Orphanet Journal of Rare Diseases (Jul 2020)

Exome sequencing for diagnosis of congenital hemolytic anemia

  • Lamisse Mansour-Hendili,
  • Abdelrazak Aissat,
  • Bouchra Badaoui,
  • Mehdi Sakka,
  • Christine Gameiro,
  • Valérie Ortonne,
  • Orianne Wagner-Ballon,
  • Serge Pissard,
  • Véronique Picard,
  • Khaldoun Ghazal,
  • Michel Bahuau,
  • Corinne Guitton,
  • Ziad Mansour,
  • Mylène Duplan,
  • Arnaud Petit,
  • Nathalie Costedoat-Chalumeau,
  • Marc Michel,
  • Pablo Bartolucci,
  • Stéphane Moutereau,
  • Benoît Funalot,
  • Frédéric Galactéros

DOI
https://doi.org/10.1186/s13023-020-01425-5
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Background Congenital hemolytic anemia constitutes a heterogeneous group of rare genetic disorders of red blood cells. Diagnosis is based on clinical data, family history and phenotypic testing, genetic analyses being usually performed as a late step. In this study, we explored 40 patients with congenital hemolytic anemia by whole exome sequencing: 20 patients with hereditary spherocytosis and 20 patients with unexplained hemolysis. Results A probable genetic cause of disease was identified in 82.5% of the patients (33/40): 100% of those with suspected hereditary spherocytosis (20/20) and 65% of those with unexplained hemolysis (13/20). We found that several patients carried genetic variations in more than one gene (3/20 in the hereditary spherocytosis group, 6/13 fully elucidated patients in the unexplained hemolysis group), giving a more accurate picture of the genetic complexity of congenital hemolytic anemia. In addition, whole exome sequencing allowed us to identify genetic variants in non-congenital hemolytic anemia genes that explained part of the phenotype in 3 patients. Conclusion The rapid development of next generation sequencing has rendered the genetic study of these diseases much easier and cheaper. Whole exome sequencing in congenital hemolytic anemia could provide a more precise and quicker diagnosis, improve patients’ healthcare and probably has to be democratized notably for complex cases.

Keywords